| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8572700 | Journal of the Association for Vascular Access | 2018 | 5 Pages |
Abstract
It is beneficial to use 1âmg alteplase for occluded CVADs. The cost of waste is nominal compared with the cost savings for the institution. The next step is to analyze other doses of alteplase to find additional areas of cost savings.
Related Topics
Health Sciences
Nursing and Health Professions
Nursing
Authors
Nellie PharmD, MPH, Edward PharmD, Karly Dancsecs,
